Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In thoracic-spinal-cord-transected rats, mean circulatory pressure (Pmc) was measured during brief circulatory arrest by inflating an indwelling balloon in the right atrium and total blood volume (VB) was measured with 51Cr. The Pmc-VB relationship was determined over the range +/- 30% VB by rapid blood infusion or withdrawal. An infusion of 1.5 microgram/kg per min of epinephrine for 20-40 minutes caused the total circulatory compliance (Ctc) to decrease 18%, the extrapolated unstressed circulatory volume (V'o) and VB to decrease 8.6 and 7.3 ml/kg, respectively, and
PMC
to increase 41% (2.6 mm Hg). Total circulatory capacity (circulatory volume at a
PMC
of 8 mm Hg) was decreased 13.7 ml/kg by epinephrine at the above infusion rate. When
vasopressin
(20 ng/kg per min) and epinephrine (0.3 microgram/kg per min) were infused together for 20-40 minutes, compared to a 0.3 microgram/kg per min infusion of epinephrine alone, the net effect of
vasopressin
was a 4.8 ml per kg decrease in VB and a 5.9 ml/kg decrease in total circulatory capacity, with insignificant decreases in CTC and V'o. The results indicate that in rats both epinephrine and
vasopressin
act to decrease blood volume via transcapillary fluid shifts, and that
vasopressin
has a relatively small overall venoconstricting action.
...
PMID:Total circulatory capacity in the rat. Effects of epinephrine and vasopressin on compliance and unstressed volume. 727 62